Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy

This study has been completed.
Forest Laboratories
Information provided by (Responsible Party):
Grünenthal GmbH Identifier:
First received: May 2, 2011
Last updated: June 5, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)